PharmiWeb34m
Global Pharmacovigilance Market Poised to Reach USD 20,902.9 Million by 2035 Amid Rising Focus on Drug Safety | Future Market Insights, Inc.
The global pharmacovigilance market is on a strong growth trajectory, with market revenue projected to expand from USD 9,000.0 million in 2025 to an estimated USD 20,902.9 million by 2035, reflecting ...
PharmiWeb2h
Global Brain Biomarkers Market is expected to surpass 11,557.3 Million by 2033 | FMI
The global brain biomarkers market is poised for remarkable growth, fueled by the escalating prevalence of neurological disorders and rapid technological advancements. A recent market analysis reveals ...
PharmiWeb3h
Global Neuronavigation Systems Market to Reach USD 4794.5 Million by 2032 amid Rising Demand for Precision Neurosurgery | FMI
The global neuronavigation systems market is set for remarkable expansion, with projections estimating a market value of USD 4,794.5 million by 2032, up from USD 2,120.0 million in 2022. This surge is ...
PharmiWeb4h
MedMira Reports Second Quarter Results FY2025
HALIFAX, NS / ACCESS Newswire / April 1, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2025.Corporate updateIn Q2 FY2025, MedMira ...
PharmiWeb9h
Total Health Revive on Why Modern Medicine is Failing Chronic Illness Patients - And What Needs to Change
Dr. Brian Anderson of Total Health Revive Shares His Insights on the Shortcomings of Conventional Healthcare in Addressing Chronic Conditions and Why Cellular Health is the Missing Link to Real ...
PharmiWeb9h
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
PharmiWeb10h
Viromed Medical AG: UMECO Group Acquires Exclusive…
PINNEBERG, DE / ACCESS Newswire / April 1, 2025 / Viromed Medical AG ("Viromed", ticker:VMED; ISIN:DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in ...
PharmiWeb10h
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced the closing of its previously announced private ...
PharmiWeb11h
Aviva Aesthetics Enters Pennsylvania, Partners with iAesthetic Medspa
CHICAGO, IL AND ERIE, PA / ACCESS Newswire / April 1, 2025 / Aviva Aesthetics is proud to announce its latest partnership with iAesthetic Medspa, a premier medical aesthetics practice in Erie, ...
PharmiWeb12h
Dr. Ammar Mahmoud Featured in Exclusive Article on the Future of Non-Invasive Cosmetic Procedures
How Technology is Reshaping Aesthetic Medicine and Expanding Patient Options NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / The field of cosmetic medicine is evolving at an unprecedented pace, ...
PharmiWeb13h
Exousia Pro Issues and Update on its FDA Orphan Drug Status
ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is ...
PharmiWeb15h
M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment
Investment/MiscellaneousM1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment01-Apr-2025 / 17:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of ...